Jang‐Whan Bae - Concepedia

Author

Jang‐Whan Bae

Also Known As

Eun-Seok Shin, Eun‐Seok Shin, Hyun-Jae Kang, J Bae, J W B Bae, J W Bae, J.W. BAE, J.W. Bae, JANG-WHAN BAE, Jang-Whan BAE

288

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Chungbuk National University Chungbuk National University Hospital Yonsei University Korea University Medical Center Sungkyunkwan University

About

Jang‐Whan Bae is an author at Chungbuk National University specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.8K
2	Public Health	8	8	223
3	Engineering	3	3	194
4	Cell Biology	3	3	460
5	Biomedical Engineering	2	2	440

Jang‐Whan Bae

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh, JAMA	2019	588
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial Bon‐Kwon Koo, Jeehoon Kang, Kyung Woo Park, The Lancet ThrombosisPercutaneous Coronary InterventionChronic Maintenance MonotherapyCardiovascular DiseaseClinical Trials	2021	322
Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and Therapeutic Efficacy for Myocardial Infarction Joo‐Yong Hahn, Hyun-Ju Cho, Hyun‐Jae Kang, Journal of the American College of Cardiology Regenerative MedicineMesenchymal Stem CellsMedicineAdult Stem CellCardiac Progenitor Cells	2008	311
Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease Jung‐Won Suh, Seung‐Pyo Lee, Kyung Woo Park, Journal of the American College of Cardiology Drug-eluting Stent ImplantationPercutaneous Coronary InterventionThrombosisCardiovascular DiseasePharmacology	2011	192
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial Hyo‐Soo Kim, Jeehoon Kang, Doyeon Hwang, The Lancet ThrombosisPercutaneous Coronary InterventionDual Antiplatelet TherapyCardiovascular DiseasePrasugrel-based De-escalation	2020	187
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Joo‐Yong Hahn, Young Bin Song, Eun Kyoung Kim, Circulation	2013	166
Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model Hainan Piao, Jin‐Sook Kwon, Shuguang Piao, Biomaterials Tissue EngineeringRegenerative MedicinePgcl ScaffoldsCardiac MuscleEngineering	2006	129
Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial Sung‐Jin Hong, Seung‐Jun Lee, Yongsung Suh, Circulation	2023	121
Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study Jeehoon Kang, Kyung Woo Park, H. K. Lee, Circulation	2022	120
mHealth Interventions for Lifestyle and Risk Factor Modification in Coronary Heart Disease: Randomized Controlled Trial Jang‐Whan Bae, Seoung-Il Woo, Joongyub Lee, JMIR mhealth and uhealth	2021	96

Page 1